Worries that Byetta might harm the pancreas have dogged the drug's makers, biotech Amylin Pharmaceuticals and drug giant Eli Lilly, for more than two years. On Monday, the FDA sent out an alert saying that it was looking into six new cases of pancreatitis, that two patients had died, and that the agency was working with Amylin "to add stronger and more prominent warnings in the product label about the risk of acute hemorrhagic or necrotizing pancreatitis."
Forbes.com
August 19, 2008
More